V. Calvaruso and A. Craxi, Why do I treat my patients with mild hepatitis C?, Liver International, vol.162, pp.7-12, 2016.
DOI : 10.7326/M14-1336

C. Ferri, M. Ramos-casals, and A. Zignego, International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement, Autoimmunity Reviews, vol.15, issue.12, pp.1145-60, 2016.
DOI : 10.1016/j.autrev.2016.09.006

P. Cacoub, C. Comarmond, F. Domont, L. Savey, A. Desbois et al., Extrahepatic manifestations of chronic hepatitis C virus infection, Therapeutic Advances in Infectious Disease, vol.15, issue.3, pp.3-14, 2016.
DOI : 10.1038/gene.2014.41
URL : https://hal.archives-ouvertes.fr/hal-01159323

M. Sayiner, M. Wymer, P. Golabi, J. Ford, I. Srishord et al., Presence of hepatitis C (HCV) infection in Baby Boomers with Medicare is independently associated with mortality and resource utilisation, Alimentary Pharmacology & Therapeutics, vol.40, issue.10, pp.1060-1068, 2016.
DOI : 10.1111/j.1475-6773.2005.00444.x

D. Center and . Control, Hepatitis C: why baby boomers should get tested Accessed 15, 2015.

V. Shahnazarian, E. Karu, and P. Mehta, Hepatitis C: improving the quality of screening in a community hospital by implementing an electronic medical record intervention, BMJ Quality Improvement Reports, vol.4, issue.1, 2015.
DOI : 10.1136/bmjquality.u208549.w3409

M. Konerman, M. Thomson, and A. Lok, Tu1660 Impact of an Electronic Medical Record (EMR) Alert on Increase in Hepatitis C Virus (HCV) Screening Rates for Baby Boomers in the Primary Care Setting, Gastroenterology, vol.150, issue.4, pp.1159-60, 2016.
DOI : 10.1016/S0016-5085(16)33917-8

M. Linthicum, Y. Gonzalez, and K. Mulligan, Value of expanding HCV screening and treatment policies in the united states, Am J Manag Care, vol.22, issue.6, pp.227-262, 2016.